¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"Transient Receptor Potential Channels"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
receptor blocker
¼ö¿ëüÂ÷´ÜÁ¦
receptor cell
¼ö¿ëü¼¼Æ÷
receptor destroying enzyme
¼ö¿ëüÆÄ±«È¿¼Ò
receptor gradient
¼ö¿ë´Ü¹é±â¿ï±â, ¼ö¿ë´Ü¹é°æ»ç, ¼ö¿ëü°æ»ç
receptor imaging
1. ¼ö¿ëü¿µ»ó 2. ¼ö¿ëü¿µ»óÈ
receptor internalization
¼ö¿ëü³»ÀçÈ
receptor site
¼ö¿ëüºÎÀ§
receptor stimulant
¼ö¿ëüÀÚ±ØÁ¦
receptor supersensitivity
¼ö¿ëüÃʹΰ¨¼º
receptor-ligand interaction
¼ö¿ëü¸®°£µå»óÈ£ÀÛ¿ë
spare receptor
¿©ºÐ¼ö¿ëü
scavenger receptor
û¼ÒÁ¦¼ö¿ëü
stretch receptor
»¸Ä§¼ö¿ë±â, ½ÅÀå¼ö¿ë±â
sensory receptor
°¨°¢¼ö¿ë±â
silent receptor
¹«¹ÝÀÀ¼ö¿ëü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
receptor internalization
¼ö¿ëü¼¼Æ÷³»À̵¿
receptor-ligand interaction
¼ö¿ëü¹èÀ§ÀÚ»óÈ£ÀÛ¿ë
joint receptor
°üÀý¼ö¿ë±â
kinesthetic receptor
¿îµ¿°¨°¢¼ö¿ëü
labyrinthine receptor
¹Ì·Î¼ö¿ëü
muscarinic receptor
¹«½ºÄ«¸°¼ö¿ëü
neuromuscular receptor
½Å°æ±ÙÀ°¼ö¿ëü
nicotinic receptor
´ÏÄÚÆ¾¼ö¿ëü
olfactory receptor
Èİ¢¼ö¿ëü
opiate receptor
¾ÆÆí¼ö¿ëü
opioid receptor
¾ÆÆíÀ¯»ç¹°Áú¼ö¿ëü
paciniform receptor
ÆÄÄ¡´ÏÇü¼ö¿ëü
postsynaptic receptor
¿¬Á¢Èļö¿ëü
prejunctional neuromuscular receptor
½Å°æ±ÙÀ°Á¢ÇÕÀü¼ö¿ëü
pressor receptor
¾Ð·Â¼ö¿ëü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
CR3 => complement receptor 3
º¸Ã¼¼ö¿ëü 3
CR4 => complement receptor 4
º¸Ã¼¼ö¿ëü 4
Gustatory receptor
¹Ì°¢¼ö¿ëü(Ú«ÊÆâ¥é»ô÷)
H2 receptor antagonist
H2 ¼ö¿ëü ±æÇ×Á¦µé
Ig receptor
¸é¿ª±Û·ÎºÒ¸° ¼ö¿ëü
Internalization, receptor
³»È(Ò®ü§), ¼ö¿ëü(áôé»ô÷)
Kainate amino acid receptor
Ä«À̳×ÀÌÆ® ¾Æ¹Ì³ë»ê ¼ö¿ëü(áôé»ô÷)
Kinesthetic receptor
¿îµ¿(ê¡ÔÑ)(°¨(Êï))°¢¼ö¿ëü(ÊÆáôé»ô÷)
NMDA receptor
¿£¾Úµð¿¡ÀÌ ¼ö¿ëü
T cell receptor
T¼¼Æ÷[Ç׿ø]¼ö¿ëü
T cell receptor gene
T¼¼Æ÷[Ç׿ø]¼ö¿ëü À¯ÀüÀÚ
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ° ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
acetylcholine receptor
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü
acetylcholine receptor antibody
¾Æ¼¼Æ¿Äݸ°¼ö¿ëüÇ×ü
acetylcholine receptor antibody assay
¾Æ¼¼Æ¿Äݸ°¼ö¿ëü Ç×Ã¼ÃøÁ¤
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
beta receptor
º£Å¸ ¼ö¿ëü(¼ö¿ë±â, °¨¼öü, °¨¼ö±â)
beta receptor blocker
º£Å¸¼ö¿ëü Â÷´ÜÁ¦( -áôé»ô÷ ó´Ó¨ð¥)
beta receptor stimulating agent
º£Å¸¼ö¿ëü ÀÚ±ØÁ¦( -áôé»ô÷ í©Ð½ð¥)
beta-ARK : beta-adrenergic receptor kinase
º£Å¸-¾Æµå·¹³¯¸°(¼º)¼ö¿ëü ÀλêÈÈ¿¼Ò.
beta-adrenergic receptor
º£Å¸ ¾Æµå·¹³¯¸°¼º ¼ö¿ëü
cardiac receptor
½ÉÀå¼ö¿ëü(ãýíôáôé»ô÷)
cell growth,ligand receptor binding
¸®°£µå¼ö¿ë±â°áÇÕ (¡áôé»ÐïÌ¿ùê)
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
cholinergic receptor
Äݸ°(ÀÛµ¿)¼º ¼ö¿ëü(¼ö¿ë±â, °¨¼ö±â)
cold receptor
³Ã°¢¼ö¿ëü(Ò²ÊÆáôé»ô÷)(¼ö¿ë±â, °¨¼ö±â)
complement receptor
º¸Ã¼¼ö¿ëü
complement receptor 1
º¸Ã¼ ¼ö¿ëü 1
complement receptor 2
º¸Ã¼¼ö¿ëü 2
complement receptor 3
º¸Ã¼¼ö¿ëü 3
complement receptor 4
º¸Ã¼¼ö¿ëü 4
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
4
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½